US Stock MarketDetailed Quotes

NTLA Intellia Therapeutics

Watchlist
  • 20.760
  • +0.740+3.70%
Close Apr 26 16:00 ET
  • 20.800
  • +0.040+0.19%
Post 18:11 ET
2.00BMarket Cap-3830P/E (TTM)

Intellia Therapeutics Stock Analyst Ratings & Price Target

Analyst Rating

Updated: Apr 10, 2024

Based on 17 analysts giving stock ratings to Intellia Therapeutics in the past 3 months

Buy

  • Buy

    70.59%
  • Hold

    29.41%
  • Sell

    0.00%

Price Target

Updated: Apr 10, 2024

The average Intellia Therapeutics stock price target is 57.62 with a max estimate of 99.00 and a min estimate of 24.00

Detailed RatingsDetailed RatingsDetailed Ratings

Detailed Ratings

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Analysis

Analyst Rating

Updated: Apr 10, 2024

Buy

  • Buy

    70.59%
  • Hold

    29.41%
  • Sell

    0.00%

Price Target

Updated: Apr 10, 2024

Heat List
US
Overall
Symbol
Latest Price
%Chg